{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"c01352c73fa7489c59479eb5984fe6df6bde1c66dddf7be3cd24c2090549c22b","attributes":{"feedName":"fda","feedSource":"fda","title":"Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply","description":"Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength).","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-losartan-potassium-25-mg-and-100-mg","publicationDate":"2019-04-26T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers","professionals"],"categories":["drugs"],"contaminants":["other"],"distribution":["CA"],"risk":"none","token":"5d9e68c78b079e002a251a58"}}}